as 12-18-2024 10:40am EST
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Founded: | 1982 | Country: | United States |
Employees: | N/A | City: | LAKEWOOD |
Market Cap: | 692.9M | IPO Year: | N/A |
Target Price: | $140.00 | AVG Volume (30 days): | 36.5K |
Analyst Decision: | Hold | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | -45.50 | EPS Growth: | N/A |
52 Week Low/High: | $83.68 - $141.17 | Next Earning Date: | 02-03-2025 |
Revenue: | $228,380,000 | Revenue Growth: | 6.88% |
Revenue Growth (this year): | 11.32% | Revenue Growth (next year): | 5.98% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Owens Gary M | MLAB | President and CEO | Oct 27 '24 | Sell | $112.80 | 5,069 | $571,735.86 | 45,888 |
MLAB Breaking Stock News: Dive into MLAB Ticker-Specific Updates for Smart Investing
Argus Research
8 days ago
Simply Wall St.
8 days ago
Argus Research
15 days ago
Argus Research
22 days ago
Argus Research
a month ago
Simply Wall St.
a month ago
Zacks
a month ago
Associated Press Finance
a month ago
The information presented on this page, "MLAB Mesa Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.